Acadia Healthcare Company, Inc. - Common Stock (ACHC)
30.46
+1.20 (4.10%)
Acadia Healthcare Company is a leading provider of behavioral healthcare services, specializing in the treatment and management of mental health and substance use disorders
With a network of facilities across the United States, Acadia operates a range of inpatient and outpatient programs designed to deliver high-quality care tailored to the unique needs of individuals facing psychological challenges. The company is committed to improving patient outcomes through evidence-based practices, compassionate treatment approaches, and a focus on fostering a supportive recovery environment. Acadia's mission is to enhance the overall well-being of its patients and communities by providing accessible and effective mental health solutions.
Shares of behavioral health company Acadia Healthcare (NASDAQACHC)
fell 24.1% in the afternoon session after the company reported weak fourth quarter results: Its revenue guidance for next quarter missed significantly and its EPS fell short of Wall Street's estimates. Overall, this was a softer quarter.
Behavioral health company Acadia Healthcare (NASDAQACHC) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 4.2% year on year to $774.2 million. Next quarter’s revenue guidance of $770 million underwhelmed, coming in 5.8% below analysts’ estimates. Its non-GAAP profit of $0.64 per share was 10.4% below analysts’ consensus estimates.
Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQACHC) today announced financial results for the fourth quarter and year ended December 31, 2024.
NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Acadia Healthcare Company, Inc. (NASDAQACHC) on behalf of long-term stockholders following a class action complaint that was filed against Acadia Healthcare on October 16, 2024 with a Class Period from February 28, 2020 to October 30, 2024. Our investigation concerns whether the board of directors of Acadia Healthcare have breached their fiduciary duties to the company.
Shareholders of Acadia Healthcare would probably like to forget the past six months even happened. The stock dropped 43.2% and now trades at $41.25. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Acadia Healthcare Company, Inc. (NasdaqGS: ACHC).
Acadia Healthcare Company, Inc. (NASDAQACHC) today announced that it will release its fourth quarter and year-end 2024 results on Thursday, February 27, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Friday, February 28, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of the conference call will be available for 30 days.
SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is investigating whether certain directors of Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQACHC) (“Defendants”) breached their fiduciary duties owed to shareholders, including during the period February 28, 2020 through the present.
KeyBanc anticipates healthcare services stocks will thrive in 2025, with growth driven by higher patient volumes and improving Medicare Advantage policies.
Acadia Healthcare Company, Inc. (NASDAQACHC) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference, January 13-16, 2025, in San Francisco, California.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Acadia Healthcare Company, Inc. (“Acadia Healthcare” or the “Company”) (NASDAQACHC) and reminds investors of the December 16, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
LOS ANGELES, CA / ACCESSWIRE / December 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia Healthcare") (NASDAQACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 30, 2024, inclusive (the "Class Period") The lead plaintiff deadline is December 16, 2024.
LOS ANGELES, CA / ACCESSWIRE / December 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
LOS ANGELES, CA / ACCESSWIRE / December 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
